If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Seok-Gu Kang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles
Glioblastoma Medicine & Life Sciences
Glioma Medicine & Life Sciences
temozolomide Medicine & Life Sciences
Mesenchymal Stromal Cells Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Neoplastic Stem Cells Medicine & Life Sciences
Survival Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2000 2019

  • 1579 Citations
  • 22 h-Index
  • 96 Article
  • 3 Conference contribution
  • 2 Letter
  • 2 Review article

Amide proton transfer imaging might predict survival and IDH mutation status in high-grade glioma

Joo, B., Han, K., Ahn, S. S., Choi, Y. S., Chang, J. H., Kang, S-G., Kim, S. H., Zhou, J. & Lee, S. K., 2019 Jan 1, In : European Radiology.

Research output: Contribution to journalArticle

Amides
Glioma
Protons
Mutation
Survival
Open Access
Intensity-Modulated Radiotherapy
Lymphopenia
Glioblastoma
temozolomide
Radiation

Combined treatment with 2′-hydroxycinnamaldehyde and temozolomide suppresses glioblastoma tumorspheres by decreasing stemness and invasiveness

Jeong, H., Park, J., Shim, J. K., Lee, J. E., Kim, N. H., Kim, H. S., Chang, J. H., Yook, J. I. & Kang, S-G., 2019 Jan 1, In : Journal of Neuro-Oncology.

Research output: Contribution to journalArticle

temozolomide
Glioblastoma
Epithelial-Mesenchymal Transition
Heterografts
Catenins
1 Citation (Scopus)

Effect of combined anti-PD-1 and temozolomide therapy in glioblastoma

Park, J., Kim, C. G., Shim, J. K., Kim, J. H., Lee, H., Lee, J. E., Kim, M. H., Haam, K., Jung, I., Park, S. H., Chang, J. H., Shin, E. C. & Kang, S-G., 2019 Jan 2, In : OncoImmunology. 8, 1, e1525243.

Research output: Contribution to journalArticle

temozolomide
Glioblastoma
Therapeutics
Neoplasms
Immunologic Memory
2 Citations (Scopus)

Immune checkpoint inhibitor-induced reinvigoration of tumor-infiltrating CD8+ T cells is determined by their differentiation status in glioblastoma

Park, J., Kwon, M., Kim, K. H., Kim, T. S., Hong, S. H., Kim, C. G., Kang, S-G., Moon, J. H., Kim, E. H., Park, S. H., Chang, J. H. & Shin, E. C., 2019 Apr 15, In : Clinical Cancer Research. 25, 8, p. 2549-2559 11 p.

Research output: Contribution to journalArticle

Glioblastoma
CTLA-4 Antigen
T-Lymphocytes
Tumor-Infiltrating Lymphocytes
Neoplasms